Back
Douglas Emmett Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
29
DEI
Douglas Emmett
Last Price:
13.38
Seasonality Move:
0.31%
Sell
35
RARE
Ultragenyx Pharmaceutical
Last Price:
38.01
Seasonality Move:
3.65%
Sell
29
Douglas Emmett (DEI)
is a Sell
Is Douglas Emmett a Buy, Sell or Hold?
- The current Douglas Emmett [DEI] share price is $13.44. The Score for DEI is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- DEI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $37.42. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DEI Stock Price Chart
What is Douglas Emmett's stock price today?
-
The Douglas Emmett share price today is $13.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DEI is experiencing buying pressure, which is a positive indicator for future bullish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $37.42
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
DEI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 48.19 | Sell |
Chaikin Money Flow: | 919547 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.16 - 14.18) | Sell |
Bollinger Bands (100): | (13.07 - 13.97) | Sell |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.58 | Sell |
Relative Strength Index (14 RSI): | 37.74 | Sell |
Chaikin Money Flow: | -836354 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.26 - 42.36) | Sell |
Bollinger Bands (100): | (41.26 - 48.86) | Sell |
DEI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.28 | Buy |
20-day SMA: | 13.47 | Sell |
50-day SMA: | 13.62 | Sell |
200-day SMA: | 13.3 | Buy |
8-day EMA: | 13.35 | Buy |
20-day EMA: | 13.49 | Sell |
50-day EMA: | 13.58 | Sell |
200-day EMA: | 13.65 | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.11 | Sell |
20-day SMA: | 40.61 | Sell |
50-day SMA: | 42.43 | Sell |
200-day SMA: | 42.45 | Sell |
8-day EMA: | 40.32 | Sell |
20-day EMA: | 40.92 | Sell |
50-day EMA: | 42.29 | Sell |
200-day EMA: | 43.55 | Sell |
Douglas Emmett Earnings Growth & DEI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.03 per share, a decrease this year of $0.07 per share, and a decrease next year of $0.24 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
Douglas Emmett Technical Analysis
Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |